THU145 Prediction Of Metabolic Syndrome Using DEXA Visceral Adipose Index (DVAI) And Pediatric Metabolic Index (PMI) In Children And Adolescents

Disclosure: K.F. Hearn: None. J.L. Fierstein: None. A. Miller: None. J.A. Canas: None. Introduction: Adverse cardiometabolic risk can be predicted during childhood using risk indices. Dual-energy absorptiometry (DEXA) derived Visceral Adipose Index (DVAI) quantifies Visceral Adipose Tissue (VAT) measured by DEXA in association with dyslipidemia. Pediatric Metabolic Index (PMI) developed for children < 18 years uses anthropometric measures validated against known pediatric markers of insulin resistance. Although Metabolic Syndrome (MetS) is prevalent among children, research on the prediction of MetS using DVAI or PMI is lacking. Aims: 1) To evaluate the predictive accuracy of MetS using DVAI and PMI. We hypothesized models using DVAI would display higher predictive accuracy than models using PMI. Methods: Retrospective review of children aged >5 to